The results revealed that immune cells known to play critical roles in anti-tumor immunity, including CD4+ T cells, CD8+ T cells, B cells, myeloid cells, and NK cells, were more abundant in the HC1LC2 group. The gene discussed is CD4; the disease is neoplasm.